In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency
Casie S. Kubota, Stephanie L. Myers, Toni T. Seppälä, Richard Andrew Burkhart, Peter John Espenshade
The paper identifies geranylgeranyl diphosphate as essential for pancreatic cancer growth through in vivo CRISPR screening and shows that targeting its synthesis reduces tumor burden.
Molecular Metabolism · May 31, 2024Peer-reviewedCell Biology